logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU overall summary in 2006 [see all tables in this series...]

Part (iii) Percentage distribution of all outpatient clients by age at first use for each primary drug

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge knownAge not known
Opiates6.340.72912.96.131.30.822.17347919741
Cocaine7.242.825.812.56.13.21.60.8224059810367
Stimulants14.26314.751.80.80.40.118.7129293389
Hypnotics and sedatives8.330.123.314.2106.13.94.124.950301840
Hallucinogens1564.8153.50.90.60.10.118.32768661
Volatile substances47.438.78.13.90.30.30.60.816.935967
Cannabis 34.354.77.420.80.40.20.2174125312256
Other substances 20.848.712.87.73.81.53.41.220.311371633
Total1446.221.79.54.62.31.10.720.617755349954

Notes:

 Countries reporting data: BG, CZ, DK, DE, IE, EL, ES, FR, IT, CY, LU, MT, NL, AT, SK, FI, SE. 

 Last data available from Spain refer to 2005. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-107 on distribution by country and '‘General notes for interpreting data'’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2007 — Table TDI — outpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Monday, 14 July 2008